Wijchen, Netherlands

Arthur A Oubrie

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 7.8

ph-index = 5

Forward Citations = 57(Granted Patents)


Location History:

  • Wychen, NL (2014 - 2015)
  • Wijchen, NL (2016 - 2021)

Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Arthur A. Oubrie: An Innovative Mind in Pharmaceutical Research

Introduction

Arthur A. Oubrie is an accomplished inventor based in Wijchen, Netherlands. With a remarkable portfolio of 9 patents, Oubrie has made significant contributions to the field of pharmaceutical research. His innovations primarily focus on developing compounds that address critical health issues, particularly in the realm of kinase inhibition.

Latest Patents

Among Oubrie's most notable recent patents are his innovative works on 4-imidazopyridazin-1-yl-benzamides. These compounds are designed as Bruton's Tyrosine Kinase (Btk) inhibitors, relating specifically to 6-5 membered fused pyridine ring compounds. The therapeutic applications of these compounds, including their use in treating Btk-mediated disorders, stand to offer new hope for patients dealing with such ailments.

Career Highlights

Oubrie's career has been marked by his roles at renowned pharmaceutical companies, including Merck Sharp & Dohme B.V. and Merck Sharp & Dohme Corporation. His tenure at these organizations has solidified his reputation as a leading innovator in drug development, contributing to the advancement of therapies aimed at combating various diseases.

Collaborations

Throughout his career, Arthur A. Oubrie has collaborated with notable peers such as Tjeerd Barf and Christiaan Gerardus Johannes Maria Jans. These collaborations reflect a shared commitment to scientific excellence and innovation, enabling Oubrie to refine his inventions and expand the impact of his research.

Conclusion

Arthur A. Oubrie exemplifies the spirit of innovation within the pharmaceutical landscape. His patents, particularly those focusing on Btk inhibitors, underscore the importance of ongoing research and development in improving treatment options. As he continues to push the boundaries of science, Oubrie remains an influential figure in the realm of inventions and pharmacology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…